Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.

MLA

Dagenais GR, et al. “Angiotensin-Converting-Enzyme Inhibitors in Stable Vascular Disease without Left Ventricular Systolic Dysfunction or Heart Failure: A Combined Analysis of Three Trials.” Lancet, vol. 368, no. 9535, Aug. 2006, pp. 581–88. EBSCOhost, https://doi.org/10.1016/s0140-6736(06)69201-5.

APA

Dagenais GR, Pogue J, Fox K, Simoons ML, & Yusuf S. (2006). Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet, 368(9535), 581–588. https://doi.org/10.1016/s0140-6736(06)69201-5

Chicago

Dagenais GR, Pogue J, Fox K, Simoons ML, and Yusuf S. 2006. “Angiotensin-Converting-Enzyme Inhibitors in Stable Vascular Disease without Left Ventricular Systolic Dysfunction or Heart Failure: A Combined Analysis of Three Trials.” Lancet 368 (9535): 581–88. doi:10.1016/s0140-6736(06)69201-5.